Circulating cytokines as mediators of fever

被引:241
作者
Netea, MG [1 ]
Kullberg, BJ [1 ]
Van der Meer, JWM [1 ]
机构
[1] Univ Nijmegen Hosp, Dept Med, Div Gen Internal Med, NL-6500 HB Nijmegen, Netherlands
关键词
D O I
10.1086/317513
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The febrile response is thought to be mediated by endogenous mediators, generically called "endogenous pyrogens," In the classical model of pathogenesis, induction of fever is mediated by the release of pyrogenic cytokines such as tumor necrosis factor (TNF), interleukin (IL)-1 IL-6, and interferons into the bloodstream in response to exogenous pyrogens. These mediators act at the level of the organum vasculosum of the lamina terminalis in the central nervous system (CNS), inducing synthesis of prostaglandins, which are the central mediators of the coordinated responses leading to fever. However, analysis of recent data suggests that multiple pathways may be involved in the induction of fever by cytokines, such as local cytokine production leading to signaling through vagal fibers, release of cytokine-induced circulating mediators at the tissue level, the use of membrane-bound cytokines as mediators, or the local release of cytokines in the hypothalamus by circulating activated monocytes, In addition, certain bacterial products can stimulate cytokine production directly at the level of hypothalamus, probably by activation of Toll-like receptors. A multipathway mechanism for the induction of fever is therefore suggested.
引用
收藏
页码:S178 / S184
页数:7
相关论文
共 85 条
[1]   A mechanism for the inhibition of fever by a virus [J].
Alcami, A ;
Smith, GL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) :11029-11034
[2]   Hyperresponsive febrile reactions to interleukin (IL) 1 alpha and IL-1 beta, and altered brain cytokine mRNA and serum cytokine levels, in IL-1 beta-deficient mice [J].
Alheim, K ;
Chai, Z ;
Fantuzzi, G ;
Hasanvan, H ;
Malinowsky, D ;
DiSanto, E ;
Ghezzi, P ;
Dinarello, CA ;
Bartfai, T .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (06) :2681-2686
[3]   PHASE-I EVALUATION OF RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH ADVANCED MALIGNANT DISEASE [J].
ATKINS, MB ;
GOULD, JA ;
ALLEGRETTA, M ;
LI, JJ ;
DEMPSEY, RA ;
RUDDERS, RA ;
PARKINSON, DR ;
REICHLIN, S ;
MIER, JW .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (09) :1380-1391
[4]   BIDIRECTIONAL TRANSPORT OF INTERLEUKIN-1-ALPHA ACROSS THE BLOOD-BRAIN-BARRIER [J].
BANKS, WA ;
KASTIN, AJ ;
DURHAM, DA .
BRAIN RESEARCH BULLETIN, 1989, 23 (06) :433-437
[5]  
BILIAU A, 1980, ANN NY ACAD SCI, V350, P374
[6]  
Blatteis CM, 1997, NEWS PHYSIOL SCI, V12, P1
[7]   REGIONAL INDUCTION OF TUMOR-NECROSIS-FACTOR ALPHA EXPRESSION IN THE MOUSE-BRAIN AFTER SYSTEMIC LIPOPOLYSACCHARIDE ADMINISTRATION [J].
BREDER, CD ;
HAZUKA, C ;
GHAYUR, T ;
KLUG, C ;
HUGININ, M ;
YASUDA, K ;
TENG, M ;
SAPER, CB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (24) :11393-11397
[8]   Both soluble and membrane-associated TNF activate brain microvascular endothelium: Relevance to multiple sclerosis [J].
Burger, D ;
Lou, J ;
Dayer, JM ;
Grau, GE .
MOLECULAR PSYCHIATRY, 1997, 2 (02) :113-116
[9]  
CANNON JG, 1989, J IMMUNOL, V142, P2299
[10]   RECOMBINANT C5A ENHANCES INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR RELEASE BY LIPOPOLYSACCHARIDE-STIMULATED MONOCYTES AND MACROPHAGES [J].
CAVAILLON, JM ;
FITTING, C ;
HAEFFNERCAVAILLON, N .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1990, 20 (02) :253-257